Trial of IDH305 in IDH1 Mutant Grade II or III Glioma
Clinical trial NCT02977689 · WITHDRAWN
Trial details
- NCT number
- NCT02977689
- Sponsor
- NYU Langone Health
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-01
- Primary completion
- 2020-04-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.